Literature DB >> 7629527

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: a clinicopathological and genetic study of a Swiss family.

H H Jung1, C Bassetti, E Tournier-Lasserve, K Vahedi, M Arnaboldi, V B Arifi, J M Burgunder.   

Abstract

This paper reports a Swiss family affected by a cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) linked to chromosome 19q12. In three generations several members of this family had recurrent stroke-like episodes and, some developed subcortical dementia, migraine-like headaches, and depression. The clinically affected family members had multiple subcortical infarcts and diffuse leukoencephalopathy on MRI. Necropsy of one patient showed a distinctive non-amyloid and non-atherosclerotic angiopathy of small cerebral and leptomeningeal arteries with concentric depositions of a basophilic granular material replacing the smooth muscle cells of the media. Linkage analysis with five chromosome 19 markers spanning the estimated CADASIL interval showed the absence of any recombinant and positive Lod scores, highly suggestive of linkage of this condition to the CADASIL locus. CADASIL might be an underestimated cause of familial stroke and should be considered in the differential diagnosis of hereditary stroke.

Entities:  

Mesh:

Year:  1995        PMID: 7629527      PMCID: PMC485988          DOI: 10.1136/jnnp.59.2.138

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  19 in total

1.  Hereditary multi-infarct dementia. Morphological and clinical studies of a new disease.

Authors:  P Sourander; J Wålinder
Journal:  Acta Neuropathol       Date:  1977-08-31       Impact factor: 17.088

2.  Presence of ultrastructural arterial lesions in muscle and skin vessels of patients with CADASIL.

Authors:  M M Ruchoux; H Chabriat; M G Bousser; M Baudrimont; E Tournier-Lasserve
Journal:  Stroke       Date:  1994-11       Impact factor: 7.914

3.  Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome.

Authors:  S G Pavlakis; P C Phillips; S DiMauro; D C De Vivo; L P Rowland
Journal:  Ann Neurol       Date:  1984-10       Impact factor: 10.422

4.  Chronic familial vascular encephalopathy.

Authors:  D L Stevens; R H Hewlett; B Brownell
Journal:  Lancet       Date:  1977-06-25       Impact factor: 79.321

Review 5.  Mendelian etiologies of stroke.

Authors:  M Natowicz; R I Kelley
Journal:  Ann Neurol       Date:  1987-08       Impact factor: 10.422

6.  [Familial hemiplegic migraine. Localization of a responsible gene on chromosome 19].

Authors:  A Joutel; M G Bousser; V Biousse; P Labauge; H Chabriat; A Nibbio; J Maciazek; B Meyer; M A Bach; J Weissenbach
Journal:  Rev Neurol (Paris)       Date:  1994       Impact factor: 2.607

7.  Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12.

Authors:  E Tournier-Lasserve; A Joutel; J Melki; J Weissenbach; G M Lathrop; H Chabriat; J L Mas; E A Cabanis; M Baudrimont; J Maciazek
Journal:  Nat Genet       Date:  1993-03       Impact factor: 38.330

8.  Autosomal dominant arteriopathic leuko-encephalopathy and Alzheimer's disease.

Authors:  F Gray; F Robert; R Labrecque; F Chrétien; M Baudrimont; C Fallet-Bianco; J Mikol; H V Vinters
Journal:  Neuropathol Appl Neurobiol       Date:  1994-02       Impact factor: 8.090

9.  Small arterial granular degeneration in familial Binswanger's syndrome.

Authors:  M Gutiérrez-Molina; A Caminero Rodríguez; C Martínez García; J Arpa Gutiérrez; C Morales Bastos; G Amer
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

10.  Autosomal dominant leukoencephalopathy and subcortical ischemic stroke. A clinicopathological study.

Authors:  M Baudrimont; F Dubas; A Joutel; E Tournier-Lasserve; M G Bousser
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

View more
  7 in total

1.  Adaptive metabolic changes in CADASIL white matter.

Authors:  Tamar Akhvlediani; Anke Henning; Peter S Sándor; Peter Boesiger; Hans H Jung
Journal:  J Neurol       Date:  2009-08-19       Impact factor: 4.849

Review 2.  Vascular dementia.

Authors:  K Amar; G Wilcock
Journal:  BMJ       Date:  1996-01-27

3.  Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: decrease in regional cerebral blood volume in hyperintense subcortical lesions inversely correlates with disability and cognitive performance.

Authors:  R Bruening; M Dichgans; C Berchtenbreiter; T Yousry; K C Seelos; R H Wu; M Mayer; G Brix; M Reiser
Journal:  AJNR Am J Neuroradiol       Date:  2001-08       Impact factor: 3.825

4.  Advanced intimal hyperplasia without luminal narrowing of leptomeningeal arteries in CADASIL.

Authors:  Hairong Dong; Haixia Ding; Kelly Young; Mila Blaivas; Paul J Christensen; Michael M Wang
Journal:  Stroke       Date:  2013-03-12       Impact factor: 7.914

5.  Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, genetic homogeneity, and mapping of the locus within a 2-cM interval.

Authors:  A Ducros; T Nagy; S Alamowitch; A Nibbio; A Joutel; K Vahedi; H Chabriat; M T Iba-Zizen; J Julien; P Davous; J Y Goas; O Lyon-Caen; B Dubois; X Ducrocq; F Salsa; M Ragno; P Burkhard; C Bassetti; M Hutchinson; M Vérin; F Viader; F Chapon; M Levasseur; J L Mas; O Delrieu
Journal:  Am J Hum Genet       Date:  1996-01       Impact factor: 11.025

Review 6.  Diagnostic criteria for CADASIL in the International Classification of Headache Disorders (ICHD-II): are they appropriate?

Authors:  Simona Sacco; Diana Degan; Antonio Carolei
Journal:  J Headache Pain       Date:  2010-03-12       Impact factor: 7.277

7.  NOTCH3 Variants and Genotype-Phenotype Features in Chinese CADASIL Patients.

Authors:  Yacen Hu; Qiying Sun; Yafang Zhou; Fang Yi; Haiyun Tang; Lingyan Yao; Yun Tian; Nina Xie; Mengchuan Luo; Zhiqin Wang; Xinxin Liao; Hongwei Xu; Lin Zhou
Journal:  Front Genet       Date:  2021-07-15       Impact factor: 4.599

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.